Studies on genotoxicity and carcinogenicity of antibacterial, antiviral, antimalarial and antifungal drugs
- 6 January 2012
- journal article
- review article
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 27 (4), 387-413
- https://doi.org/10.1093/mutage/ger094
Abstract
This review provides a compendium of retrievable results of genotoxicity and animal carcinogenicity studies performed of antibacterial, antiviral, antimalarial and antifungal drugs of long-term or intermittent frequent use. Of the 48 drugs considered, 9 (18.75%) do not have retrievable data, whereas the other 39 (81.25%) have at least one genotoxicity or carcinogenicity tests result. Of these 39 drugs, 24 tested positive in at least one genotoxicity assay and 19 in at least one carcinogenicity assay; 14 of them gave a positive response in both at least one genotoxicity assay and at least one carcinogenicity assay. Concerning the predictivity of genetic toxicology findings for the results of long-term carcinogenesis assays, of 23 drugs with both genotoxicity and carcinogenicity data: 2 (8.7%) were neither genotoxic nor carcinogenic, 2 (8.7%) tested positive in at least one genotoxicity assay but were non-carcinogenic, 4 (17.4%) tested negative in genotoxicity assays but were carcinogenic, and 15 (65.2%) gave a positive response in at least one genotoxicity assay and in at least one carcinogenicity assay. Only 18 (37.5%) of the 48 drugs examined had all data required by present guidelines for testing of pharmaceuticals, but a fraction of them (49%) were developed and marketed prior to the present regulatory climate. In the absence of compelling indications, the prescription of the 19 drugs that are animal carcinogens should be avoided.Keywords
This publication has 44 references indexed in Scilit:
- Comparative analysis of DNA breakage, chromosomal aberrations and apoptosis induced by the anti-herpes purine nucleoside analogues aciclovir, ganciclovir and penciclovirMutation research. Reviews in mutation research, 2002
- A review of the genotoxicity of marketed pharmaceuticalsMutation research. Reviews in mutation research, 2001
- ICH-Harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impactMutation research. Reviews in mutation research, 1999
- Preclinical toxicology studies with azithromycin: genetic toxicology evaluationMutation Research/Genetic Toxicology, 1993
- The comparative responses of Salmonella typhimurium TA1537 and TA97a to a range of reference mutagens and novel compoundsMutagenesis, 1990
- Influence of the Uvr repair system on the mutagenicity of antiparasitic drugsMutation Research/Genetic Toxicology, 1989
- A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell culturesMutation Research/Reviews in Genetic Toxicology, 1988
- Frameshift mutagenesis by chloroquine in Escherichia coli and Salmonella typhimuriumMutation Research Letters, 1987
- Mutagenicity examination of several non-steroidal anti-inflammatory drugs in bacterial systemsMutation Research/Genetic Toxicology, 1984
- Evaluation of microbial testing methods for the mutagenicity of quinoline and its derivativesCurrent Microbiology, 1984